Kitalys Institute, Inc.

What Kitalys Institute, Inc. does

Kitalys Institute, Inc. is a not-for-profit organization founded in 2020 by Dr. Alexander Fleming and spun out of Kinexum, a strategic advisory firm focused on metabolism, diabetes, and aging-related therapeutics. Headquartered in Charlottesville, Virginia, the institute's mission is to translate geroscience and healthy-longevity research into actionable public health policy in the United States and internationally. Its work targets federal-level engagement with agencies including the FDA and the National Institute on Aging, as well as Congressional staff and foundation funders.

The institute's core product is the Targeting Healthy Longevity (THL) Sessions, a recurring conference series that has accumulated over 200 hours of recorded expert dialogue covering the biology of aging, clinical translation, regulatory pathways, and healthspan science. Layered on this program are several substantive initiatives: the THRIVE Act (a proposed federal legislative framework), Project Healthspan (laying out a national healthy-longevity agenda), Project Endpoints (focused on defining and validating healthspan measurement endpoints for trials), and the Healthspan Equity initiative. Programming is delivered through live Zoom sessions and, since 2025, on-demand webcasts on YouTube, giving the institute a global reach disproportionate to the size of its team.

The business model is that of a public charity. Operating funding derives from individual donations, philanthropic contributions, and in-kind support; programming and content are distributed free of charge to maximize access for researchers, policymakers, industry stakeholders, and the general public. The organization runs with a small core staff of approximately four people supplemented by an advisory board and a curated network of academic, agency, and industry speakers. Strategic coalition partners include the Healthspan Action Coalition, the Asia-Pacific Longevity Medicine Society, XPRIZE, ARPA-H, the National Academy of Medicine, and the founding firm Kinexum.

Name

Kitalys Institute, Inc.

Legal name

The Kitalys Institute

Website

https://kitalys.org

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Kitalys Institute is a 501(c)(3) nonprofit founded in 2020 by Dr. Alexander Fleming that translates geroscience and healthy-longevity research into public health policy. It operates the Targeting Healthy Longevity Sessions, the THRIVE Act initiative, and healthspan-related projects, funded by charitable donations and distributed free worldwide.

Ownership category

akta.pro rank

Product category

Public Health Policy Advocacy

NAICS

Social Advocacy Organizations (8133), Research and Development in the Social Sciences and Humanities (54172)

SIC

Services-Social Services (8300)

akta.pro primary industry

Think Tanks, Policy Research & Public Policy Institutes (BPAGAFAO)

akta.pro secondary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

• Longevity policy advocacy
• Healthspan legislation
• Geroscience education
• Public health convening
• Regulatory pathway research

Headquarters

HQ city

Charlottesville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Donations and Charitable Contributions: As a not-for-profit organization, Kitalys Institute relies on donations from individuals and organizations who support the mission of extending healthy longevity. The website includes a PayPal donation option.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

The Kitalys Institute is a not-for-profit advocacy and convening organization that translates geroscience into public health policy. It produces and hosts free virtual Targeting Healthy Longevity sessions and webcasts featuring expert panels of scientists, clinicians, policymakers, and industry executives, develops draft federal legislation including the THRIVE Act (a tiered regulatory pathway proposal for healthspan products), and runs advocacy initiatives such as Project Healthspan, Project Endpoints, and Healthspan Equity.

Product overview

The Kitalys Institute is a not-for-profit organization (formed in 2020 by Dr. Alexander Fleming through Kinexum) that operates as a think tank and advocacy organization rather than a commercial product company. Its core offerings include the Targeting Healthy Longevity Sessions (a free virtual conference series featuring expert discussions on geroscience and longevity), the THRIVE Act (proposed federal legislation for a tiered regulatory pathway for healthspan products), Project Healthspan (advocacy for federal healthspan legislation), Project Endpoints (identifying longevity-related clinical endpoints), and Healthspan Equity (ensuring equitable access to healthspan advances). The organization publicizes scientific discoveries through YouTube webcasts and coordinates with global organizations including the Asia-Pacific Longevity Medicine Society.

Differentiator

Problem solved

Functional benefit

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and minor.

• Healthspan Action Coalition (HSAC)coreStrategic or Co-development PartnerKitalys Institute partnered with Healthspan Action Coalition to develop the THRIVE Act draft legislation. HSAC is a coalition advocating for healthspan research and policy. Together they coordinate advocacy efforts for federal legislation encouraging healthspan product development.
• Asia-Pacific Longevity Medicine SocietycoreStrategic or Co-development PartnerKitalys Institute is partnering with the Asia-Pacific Longevity Medicine Society to present the Asia-Pacific Healthy Longevity International Summit in Hong Kong (October 1-4, 2026). This is the second annual summit co-organized by both organizations.
• XPRIZE HealthspanminorStrategic or Co-development PartnerKitalys Institute has advised XPRIZE Healthspan ($101 million competition) on strategic regulatory matters. Kinexum (related company) represents longevity biotechnology companies including XPRIZE Healthspan semifinalists.
• ARPA-H PROSPRminorStrategic or Co-development PartnerKitalys Institute advised ARPA-H PROSPR program (funding multi-modal approaches to healthspan) on strategic regulatory matters.
• National Academy of MedicineminorStrategic or Co-development PartnerKitalys Institute coordinates with the National Academy of Medicine as part of its advocacy and coalition-building efforts for healthspan policy.
• National Institute on Aging (NIA)minorStrategic or Co-development PartnerKitalys Institute engages with NIA as part of its collaborative efforts to advance longevity science and policy.
• FDAminorStrategic or Co-development PartnerKitalys Institute works with FDA as part of its mission to improve regulatory pathways for healthspan products and translate science into policy.
• KinexumcoreStrategic or Co-development PartnerKitalys Institute was created by Kinexum (strategic advisory firm for life science product development). Dr. Alexander Fleming is founder and Executive Chair of Kinexum. Kitalys and Kinexum jointly organize the Targeting Healthy Longevity conference since 2017. Thomas Seoh is CEO of Kinexum and EVP of Kitalys Institute.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• SENS Research Foundation: Nonprofit focused on developing and promoting regenerative medicine approaches to prevent age-related disease. Operates in the same geroscience-to-public-health translation lane as Kitalys, though with a more research-funding model.
• Asia-Pacific Longevity Medicine Society: Kitalys's direct co-organizer of the Asia-Pacific Healthy Longevity International Summit and regional partner for international expansion. Operates in the same convening and education lane but with regional (Asia-Pacific) focus.
• Alliance for Aging Research: Established nonprofit advocating for aging research and healthspan policy in Washington, D.C. Operates in the same federal policy advocacy lane as Kitalys, targeting Congress, NIH, and FDA to advance interventions that extend healthy lifespan.
• American Federation for Aging Research (AFAR): Long-standing nonprofit funding and advocating for aging research and the translation of geroscience into healthspan outcomes. Shares Kitalys's mission of moving longevity science from the lab into public health practice and policy.
• Healthspan Action Coalition: Coalition co-developer of the THRIVE Act and Kitalys's closest policy partner. HSAC advocates for the same federal healthspan regulatory pathway and shares the same target audience of policymakers and longevity stakeholders, making it a direct peer in healthspan policy advocacy.
• International Longevity Centre (UK): UK-based think tank focused on the impact of population aging on health, financial security, and public policy. Operates as a policy research and advocacy organization with similar structure and audience to Kitalys.
• Methuselah Foundation: Longevity-focused nonprofit funding research and building the regenerative medicine ecosystem. Comparable mission profile of advancing healthspan through advocacy, funding, and ecosystem-building.

Broad incumbents

• XPRIZE Healthspan: $101 million global competition to develop therapeutic solutions for healthy aging. Operates at vastly larger scale and budget than Kitalys in the same healthspan space; Kitalys has advised XPRIZE Healthspan on regulatory matters, evidencing overlap.
• National Academy of Medicine: Influential U.S. policy research institution addressing health, biomedical science, and medicine. Kitalys coordinates with NAM on healthspan policy advocacy, and NAM's authoritative role in setting national health priorities makes it a high-relevance adjacent peer.

Others

• ARPA-H PROSPR: U.S. federal program funding multi-modal approaches to healthspan. Kitalys has advised ARPA-H PROSPR on strategic regulatory matters; ARPA-H operates as a funder rather than an advocacy organization, making it an ecosystem participant rather than a direct competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@kitalysinstitute9500/featured
• LinkedInlinkedin.com/company/kitalys-institute

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kitalys Institute, Inc.